Infection, inflammation, and bone regeneration: A paradoxical relationship

Journal of Dental Research

Volumn 90, Issue 9, 2011, Pages 1052-1061

  Thomas, M V ^a   Puleo, D A ^b  

^a UNIVERSITY OF KENTUCKY COLLEGE OF DENTISTRY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

bone; cytokines; infection; inflammation; regeneration

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANTIINFECTIVE AGENT; ARACHIDONIC ACID; AUTACOID; BONE MORPHOGENETIC PROTEIN 2; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL; ARTIFICIAL MEMBRANE; BIOSYNTHESIS; BONE REGENERATION; DIABETES MELLITUS; HUMAN; IMMUNOLOGY; INFECTION; INFLAMMATION; METABOLISM; PERIODONTICS; PHYSIOLOGY; REVIEW; TOOTH IMPLANTATION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONIC ACID; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; CYTOKINES; DENTAL IMPLANTS; DIABETES MELLITUS; GLYCOSYLATION END PRODUCTS, ADVANCED; GUIDED TISSUE REGENERATION, PERIODONTAL; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MEMBRANES, ARTIFICIAL; NF-KAPPA B; NITRIC OXIDE; PROSTHESIS-RELATED INFECTIONS;

EID: 80051711507     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034510393967     Document Type: Review

References (142)

1. Adams CS, Antoci V, Harrison G, Patal P, Freeman TA, Shapiro IM, et al. Controlled release of vancomycin from thin sol-gel films on implant surfaces successfully controls osteomyelitis. J Orthop Res. 2009 ; 27: 701-709
2. Aliberti J, Hieny S, Reis e Sousa C, Serhan CN, Sher A. Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nat Immunol. 2002a ; 3: 76-82 (Pubitemid 34065621)
3. Aliberti J, Serhan C, Sher A. Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection. J Exp Med. 2002b ; 196: 1253-1262 (Pubitemid 35304190)
4. Alissa R, Sakka S, Oliver R, Horner K, Esposito M, Worthington HV, et al. Influence of ibuprofen on bone healing around dental implants: a randomised double-blind placebo-controlled clinical study. Eur J Oral Implantol. 2009 ; 2: 185-199
5. Allen HL, Wase A, Bear WT. Indomethacin and aspirin: effect of nonsteroidal anti-inflammatory agents on the rate of fracture repair in the rat. Acta Orthop Scand. 1980 ; 51: 595-600 (Pubitemid 10090468)
6. Antoci V, Adams CS, Parvizi J, Ducheyne P, Shapiro IM, Hickok NJ. Covalently attached vancomycin provides a nanoscale antibacterial surface. Clin Orthop Relat Res. 2007a ; 461: 81-87 (Pubitemid 47344098)
7. Antoci V, Adams CS, Hickok NJ, Shapiro IM, Parvizi J. Vancomycin bound to Ti rods reduces periprosthetic infection: preliminary study. Clin Orthop Relat Res. 2007b ; 461: 88-95 (Pubitemid 47344099)
8. Antoci V, King SB, Jose B, Parvizi J, Zeiger AR, Wickstrom E, et al. Vancomycin covalently bonded to titanium alloy prevents bacterial colonization. J Orthop Res. 2007c ; 25: 858-866 (Pubitemid 47046432)
9. Antoci V, Adams CS, Parvizi J, Davidson HM, Composto RJ, Freeman TA, et al. The inhibition of Staphylococcus epidermidis biofilm formation by vancomycin-modified titanium alloy and implications for the treatment of periprosthetic infection. Biomaterials. 2008 ; 29: 4684-4690
10. Apatzidou DA. One stage full-mouth disinfection-treatment of choice?. J Clin Periodontol. 2006 ; 33: 942-943 (Pubitemid 44715436)
11. Armour KJ, Armour KE, van't Hof RJ, Reid DM, Wei XQ, Liew FY, et al. Activation of the inducible nitric oxide synthase pathway contributes to inflammation-induced osteoporosis by suppressing bone formation and causing osteoblast apoptosis. Arthritis Rheum. 2001 ; 44: 2790-2796 (Pubitemid 34016198)
12. Baker PJ, Dixon M, Evans RT, Dufour L, Johnson E, Roopenian DC. CD4(+) T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infect Immun. 1999 ; 67: 2804-2809 (Pubitemid 29244693)
13. Balga R, Wetterwald A, Portenier J, Dolder S, Mueller C, Hofstetter W. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro. Bone. 2006 ; 39: 325-335 (Pubitemid 43851380)
14. Bandeira-Melo C, Serra MF, Diaz BL, Cordeiro RS, Silva PM, Lenzi HL, et al. Cyclooxygenase-2-derived prostaglandin E2 and lipoxin A4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: relationship with concurrent eosinophilia. J Immunol. 2000 ; 164: 1029-1036 (Pubitemid 30043731)
15. Benoit MA, Mousset B, Delloye C, Bouillet R, Gillard J. Antibiotic-loaded plaster of Paris implants coated with poly lactide-co-glycolide as a controlled release delivery system for the treatment of bone infections. Int Orthop. 1997 ; 21: 403-408 (Pubitemid 28055132)
16. Bergenstock M, Min W, Simon AM, Sabatino C, O'Connor JP. A comparison between the effects of acetaminophen and celecoxib on bone fracture healing in rats. J Orthop Trauma. 2005 ; 19: 717-723 (Pubitemid 44378210)
17. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature. 1986 ; 319: 516-518 (Pubitemid 16212936)
18. Blanchard F, Duplomb L, Baud'huin M, Brounais B. The dual role of IL-6-type cytokines on bone remodeling and bone tumors. Cytokine Growth Factor Rev. 2009 ; 20: 19-28
19. Bollen CM, Mongardini C, Papaioannou W, Van Steenberghe D, Quirynen M. The effect of a one-stage full-mouth disinfection on different intra-oral niches. Clinical and microbiological observations. J Clin Periodontol. 1998 ; 25: 56-66 (Pubitemid 128705997)
20. Boyce BF, Xing L, Franzoso G, Siebenlist U. Required and nonessential functions of nuclear factor-kappa B in bone cells. Bone. 1999 ; 25: 137-139 (Pubitemid 29322078)
21. Brick KE, Chen X, Lohr J, Schmidt AH, Kidder LS, Lew WD. rhBMP-2 modulation of gene expression in infected segmental bone defects. Clin Orthop Relat Res. 2009 ; 467: 3096-3103
22. Brocard D, Barthet P, Baysse E, Duffort JF, Eller P, Justumus P, et al. A multicenter report on 1,022 consecutively placed ITI implants: a 7-year longitudinal study. Int J Oral Maxillofac Implants. 2000 ; 15: 691-700
23. Brown KD, Claudio E, Siebenlist U. The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis. Arthritis Res Ther. 2008 ; 10: 212
24. Buser D, Mericske-Stern R, Bernard JP, Behneke A, Behneke N, Hirt HP, et al. Long-term evaluation of non-submerged ITI implants. Part 1: 8-year life table analysis of a prospective multi-center study with 2359 implants. Clin Oral Implants Res. 1997 ; 8: 161-172 (Pubitemid 127688451)
25. Buser D, Mericske-Stern R, Dula K, Lang NP. Clinical experience with one-stage, non-submerged dental implants. Adv Dent Res. 1999 ; 13: 153-161
26. Chambers TJ, Fox S, Jagger CJ, Lean JM, Chow JW. The role of prostaglandins and nitric oxide in the response of bone to mechanical forces. Osteoarthritis Cartilage. 1999 ; 7: 422-423 (Pubitemid 29331568)
27. Chang J, Wang Z, Tang E, Fan Z, McCauley L, Franceschi R, et al. Inhibition of osteoblastic bone formation by nuclear factor-kappaB. Nat Med. 2009 ; 15: 682-689
28. Chen X, Schmidt AH, Tsukayama DT, Bourgeault CA, Lew WD. Recombinant human osteogenic protein-1 induces bone formation in a chronically infected, internally stabilized segmental defect in the rat femur. J Bone Joint Surg Am. 2006 ; 88: 1510-1523
29. Chen X, Schmidt AH, Mahjouri S, Polly DW, Lew WD. Union of a chronically infected internally stabilized segmental defect in the rat femur after debridement and application of rhBMP-2 and systemic antibiotic. J Orthop Trauma. 2007 ; 21: 693-700 (Pubitemid 350073453)
30. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999 ; 284: 1318-1322 (Pubitemid 29289651)
31. Costerton JW, Montanaro L, Arciola CR. Biofilm in implant infections: its production and regulation. Int J Artif Organs. 2005 ; 28: 1062-1068 (Pubitemid 43085399)
32. Cottrell JA, O'Connor JP. Pharmacological inhibition of 5-lipoxygenase accelerates and enhances fracture-healing. J Bone Joint Surg Am. 2009 ; 91: 2653-2665
33. Darouiche RO. Antimicrobial approaches for preventing infections associated with surgical implants. Clin Infect Dis. 2003 ; 36: 1284-1289 (Pubitemid 36629939)
34. Del Fattore A, Cappariello A, Teti A. Genetics, pathogenesis and complications of osteopetrosis. Bone. 2008 ; 42: 19-29 (Pubitemid 350297169)
35. DiBattista P, Bissada NF, Ricchetti PA. Comparative effectiveness of various regenerative modalities for the treatment of localized juvenile periodontitis. J Periodontol. 1995 ; 66: 673-678
36. Dimar JR, Ante WA, Zhang YP, Glassman SD. The effects of nonsteroidal anti-inflammatory drugs on posterior spinal fusions in the rat. Spine (Phila Pa 1976). 1996 ; 21: 1870-1876 (Pubitemid 26279596)
37. Dimitriou R, Tsiridis E, Giannoudis PV. Current concepts of molecular aspects of bone healing. Injury. 2005 ; 36: 1392-1404 (Pubitemid 41618169)
38. Diwan AD, Khan SN, Cammisa FP, Sandhu HS, Lane JM. Nitric oxide modulates recombinant human bone morphogenetic protein-2-induced corticocancellous autograft incorporation: a study in rat intertransverse fusion. Eur Spine J. 2010 ; 19: 931-939
39. Edupuganti OP, Antoci V, King SB, Jose B, Adams CS, Parvizi J, et al. Covalent bonding of vancomycin to Ti6A14V alloy pins provides long-term inhibition of Staphylococcus aureus colonization. Bioorg Med Chem Lett. 2007 ; 17: 2692-2696 (Pubitemid 46636269)
40. Filleul O, Crompot E, Saussez S. Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases. J Cancer Res Clin Oncol. 2010 ; 136: 1117-1124
41. Fukada SY, Silva TA, Saconato IF, Garlet GP, Avila-Campos MJ, Silva JS, et al. iNOS-derived nitric oxide modulates infection-stimulated bone loss. J Dent Res. 2008 ; 87: 1155-1159
42. Fuller K, Chambers TJ. Effect of arachidonic acid metabolites on bone resorption by isolated rat osteoclasts. J Bone Miner Res. 1989 ; 4: 209-215 (Pubitemid 19121795)
43. Gaffen SL. An overview of IL-17 function and signaling. Cytokine. 2008 ; 43: 402-407
44. Gaffen SL, Hajishengallis G. A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. J Dent Res. 2008 ; 87: 817-828
45. Garrett S. Periodontal regeneration around natural teeth. Ann Periodontol. 1996 ; 1: 621-666
46. Garrett-Sinha LA, John S, Gaffen SL. IL-17 and the Th17 lineage in systemic lupus erythematosus. Curr Opin Rheumatol. 2008 ; 20: 519-525
47. Gerstenfeld LC, Cho TJ, Kon T, Aizawa T, Cruceta J, Graves BD, et al. Impaired intramembranous bone formation during bone repair in the absence of tumor necrosis factor-alpha signaling. Cells Tissues Organs. 2001 ; 169: 285-294 (Pubitemid 32656656)
48. Gerstenfeld LC, Cullinane DM, Barnes GL, Graves DT, Einhorn TA. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem. 2003 ; 88: 873-884 (Pubitemid 36337032)
49. Gerstenfeld LC, Al-Ghawas M, Alkhiary YM, Cullinane DM, Krall EA, Fitch JL, et al. Selective and nonselective cyclooxygenase-2 inhibitors and experimental fracture-healing. Reversibility of effects after short-term treatment. J Bone Joint Surg Am. 2007 ; 89: 114-125 (Pubitemid 46059150)
50. Glassman SD, Rose SM, Dimar JR, Puno RM, Campbell MJ, Johnson JR. The effect of postoperative nonsteroidal anti-inflammatory drug administration on spinal fusion. Spine (Phila Pa 1976). 1998 ; 23: 834-838 (Pubitemid 28169215)
51. Gorny G, Shaw A, Oursler MJ. IL-6, LIF, and TNF-alpha regulation of GM-CSF inhibition of osteoclastogenesis in vitro. Exp Cell Res. 2004 ; 294: 149-158 (Pubitemid 38229789)
52. Graves D. Cytokines that promote periodontal tissue destruction. J Periodontol. 2008 ; 79 (8 Suppl). 1585S - 1591S
53. Graves DT, Cochran D. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol. 2003 ; 74: 391-401 (Pubitemid 36939356)
54. Graves DT, Oskoui M, Volejnikova S, Naguib G, Cai S, Desta T, et al. Tumor necrosis factor modulates fibroblast apoptosis, PMN recruitment, and osteoclast formation in response to P. gingivalis infection. J Dent Res. 2001 ; 80: 1875-1879 (Pubitemid 33038053)
55. Gyurko R, Shoji H, Battaglino RA, Boustany G, Gibson FC, Genco CA, et al. Inducible nitric oxide synthase mediates bone development and P. gingivalis-induced alveolar bone loss. Bone. 2005 ; 36: 472-479 (Pubitemid 40403845)
56. Harder AT, An YH. The mechanisms of the inhibitory effects of nonsteroidal anti-inflammatory drugs on bone healing: a concise review. J Clin Pharmacol. 2003 ; 43: 807-815 (Pubitemid 36886100)
57. Harrison JR, Kleinert LM, Kelly PL, Krebsbach PH, Woody C, Clark S, et al. Interleukin-1 represses COLIA1 promoter activity in calvarial bones of transgenic ColCAT mice in vitro and in vivo. J Bone Miner Res. 1998 ; 13: 1076-1083 (Pubitemid 28311775)
58. Harten RD, Svach DJ, Schmeltzer R, Uhrich KE. Salicylic acid-derived poly(anhydride-esters) inhibit bone resorption and formation in vivo. J Biomed Mater Res A. 2005 ; 72: 354-362 (Pubitemid 40315849)
59. Hasturk H, Kantarci A, Ohira T, Arita M, Ebrahimi N, Chiang N, et al. RvE1 protects from local inflammation and osteoclast-mediated bone destruction in periodontitis. FASEB J. 2006 ; 20: 401-403 (Pubitemid 46671185)
60. Havemose-Poulsen A, Holmstrup P. Factors affecting IL-1-mediated collagen metabolism by fibroblasts and the pathogenesis of periodontal disease: a review of the literature. Crit Rev Oral Biol Med. 1997 ; 8: 217-236 (Pubitemid 27217170)
61. Hirose K, Marui A, Arai Y, Nomura T, Kaneda K, Kimura Y, et al. A novel approach to reduce catheter-related infection using sustained-release basic fibroblast growth factor for tissue regeneration in mice. Heart Vessels. 2007 ; 22: 261-267 (Pubitemid 47177149)
62. Horowitz M, Kacena M, Lorenzo J Bone resorption. Bronner F Farach-Carson M Rubin J, ed. London: Springer-Verlag ; 2005: 91-107.
63. Janssens S, Beyaert R. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol Cell. 2003 ; 11: 293-302 (Pubitemid 36293825)
64. Jeffcoat MK, Williams RC, Reddy MS, English R, Goldhaber P. Flurbiprofen treatment of human periodontitis: effect on alveolar bone height and metabolism. J Periodontal Res. 1988 ; 23: 381-385
65. Ji Y, Xu GP, Zhang ZP, Xia JJ, Yan JL, Pan SH. BMP-2/PLGA delayed-release microspheres composite graft, selection of bone particulate diameters, and prevention of aseptic inflammation for bone tissue engineering. Ann Biomed Eng. 2010 ; 38: 632-639
66. Katayama Y, Akatsu T, Yamamoto M, Kugai N, Nagata N. Role of nonenzymatic glycosylation of type I collagen in diabetic osteopenia. J Bone Miner Res. 1996 ; 11: 931-937 (Pubitemid 26200043)
67. Kawasaki K, Gao YH, Yokose S, Kaji Y, Nakamura T, Suda T, et al. Osteoclasts are present in gp130-deficient mice. Endocrinology. 1997 ; 138: 4959-4965 (Pubitemid 27460936)
68. Keller J, Bunger C, Andreassen TT, Bak B, Lucht U. Bone repair inhibited by indomethacin. Effects on bone metabolism and strength of rabbit osteotomies. Acta Orthop Scand. 1987 ; 58: 379-383 (Pubitemid 17149867)
69. Kinane DF, Attström R. Advances in the pathogenesis of periodontitis. Group B consensus report of the fifth European Workshop in Periodontology. J Clin Periodontol. 2005 ; 32 (Suppl 6). 130-131 (Pubitemid 41391061)
70. Kirkwood K, Taba M, Rossa C, Preshaw PM, Giannobile WV Carranza's Clinical periodontology. Newman M Takei H Klokkevold PR Carranza FA, ed. St. Louis: Saunders-Elsevier ; 2006: 259-274.
71. Koenders MI, Lubberts E, van de Loo FA, Oppers-Walgreen B, van den Bersselaar L, Helsen MM, et al. Interleukin-17 acts independently of TNF-alpha under arthritic conditions. J Immunol. 2006 ; 176: 6262-6269
72. Kon T, Cho TJ, Aizawa T, Yamazaki M, Nooh N, Graves D, et al. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res. 2001 ; 16: 1004-1014 (Pubitemid 32467144)
73. Kornman KS. Mapping the pathogenesis of periodontitis: a new look. J Periodontol. 2008 ; 79 (8 Suppl). 1560S - 1568S
74. Koshy G, Corbet EF, Ishikawa I. A full-mouth disinfection approach to nonsurgical periodontal therapy-prevention of reinfection from bacterial reservoirs. Periodontol 2000. 2004 ; 36: 166-178 (Pubitemid 41694993)
75. Kumar V, Abbas A, Fausto N Pathologic basis of disease. Kumar V Abbas A Fausto N, ed. St. Louis: Saunders-Elsevier ; 2005a: 47-86.
76. Kumar V, Abbas A, Fausto N Pathologic basis of disease. Kumar V Abbas A Fausto N, ed. St. Louis: Saunders-Elsevier ; 2005b: 87-118.
77. Lalla E, Lamster IB, Feit M, Huang L, Spessot A, Qu W, et al. Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. J Clin Invest. 2000 ; 105: 1117-1124 (Pubitemid 30217696)
78. Landa J, Margolis N, Di Cesare P. Orthopaedic management of the patient with osteopetrosis. J Am Acad Orthop Surg. 2007 ; 15: 654-662
79. Leonelli SM, Goldberg BA, Safanda J, Bagwe MR, Sethuratnam S, King SJ. Effects of a cyclooxygenase-2 inhibitor (rofecoxib) on bone healing. Am J Orthop (Belle Mead NJ). 2006 ; 35: 79-84
80. Lindholm TS, Tornkvist H. Inhibitory effect on bone formation and calcification exerted by the anti-inflammatory drug ibuprofen. An experimental study on adult rat with fracture. Scand J Rheumatol. 1981 ; 10: 38-42 (Pubitemid 11114040)
81. Lynch SE Bone regeneration and repair: biology and clinical applications. Lieberman JR Friedlaender GE, ed. Totowa, NJ: Humana Press ; 2010: 359-390.
82. Manolagas SC, Bellido T, Jilka RL. New insights into the cellular, biochemical, and molecular basis of postmenopausal and senile osteoporosis: roles of IL-6 and gp130. Int J Immunopharmacol. 1995 ; 17: 109-116
83. Martin GJ, Boden SD, Titus L. Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion. Spine (Phila Pa 1976). 1999 ; 24: 2188-2193
84. McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007 ; 7: 429-442 (Pubitemid 46834849)
85. Miyata T, Notoya K, Yoshida K, Horie K, Maeda K, Kurokawa K, et al. Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. J Am Soc Nephrol. 1997 ; 8: 260-270 (Pubitemid 127455881)
86. Miyaura C, et al. Impaired bone resorption to prostaglandin E2 in prostaglandin E receptor EP4-knockout mice. J Biol Chem. 2000 ; 26: 19819-19823 (Pubitemid 30441583)
87. Moojen DJ, Vogely HC, Fleer A, Nikkels PG, Higham PA, Verbout AJ, et al. Prophylaxis of infection and effects on osseointegration using a tobramycin-periapatite coating on titanium implants-an experimental study in the rabbit. J Orthop Res. 2009 ; 27: 710-716
88. Mountziaris PM, Mikos AG. Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng Part B Rev. 2008 ; 14: 179-186 (Pubitemid 351839215)
89. Mousset B, Benoit MA, Delloye C, Bouillet R, Gillard J. Biodegradable implants for potential use in bone infection. An in vitro study of antibiotic-loaded calcium sulphate. Int Orthop. 1995 ; 19: 157-161
90. Nair SP, Meghji S, Wilson M, Reddi K, White P, Henderson B. Bacterially induced bone destruction: mechanisms and misconceptions. Infect Immun. 1996 ; 64: 2371-2380 (Pubitemid 26226792)
91. Nakalekha C, Yokoyama C, Miura H, Alles N, Aoki K, Ohya K, et al. Increased bone mass in adult prostacyclin-deficient mice. J Endocrinol. 2010 ; 204: 125-133
92. Nanes M, Pacifici R Bone resorption. Bronner F Farach-Carson M Rubin J, ed. New York: Springer ; 2005: 67-90.
93. Needleman IG, Worthington HV, Giedrys-Leeper E, Tucker RJ. Guided tissue regeneration for periodontal infra-bony defects. Cochrane Database Syst Rev. 2006 ; 2 :
94. Newman MG. The role of infection and anti-infection treatment in regenerative therapy. J Periodontol. 1993 ; 64 (11 Suppl). 1166S - 1170S
95. Nisengard RJ, Haake SK, Newman MG, Miyasaki KT Carranza's Clinical periodontology. Newman MG Takei H Klokkevold PR Carranza FA, ed. St. Louis: Saunders-Elsevier ; 2006: 228-250.
96. Nowzari H, Slots J. Microorganisms in polytetrafluoroethylene barrier membranes for guided tissue regeneration. J Clin Periodontol. 1994 ; 21: 203-210
97. Nowzari H, Matian F, Slots J. Periodontal pathogens on polytetrafluoroethylene membrane for guided tissue regeneration inhibit healing. J Clin Periodontol. 1995 ; 22: 469-474
98. Nowzari H, MacDonald ES, Flynn J, London RM, Morrison JL, Slots J. The dynamics of microbial colonization of barrier membranes for guided tissue regeneration. J Periodontol. 1996 ; 67: 694-702 (Pubitemid 126613048)
99. Nyman S, Lindhe J, Karring T, Rylander H. New attachment following surgical treatment of human periodontal disease. J Clin Periodontol. 1982 ; 9: 290-296
100. Obeid G, Zhang X, Wang X. Effect of ibuprofen on the healing and remodeling of bone and articular cartilage in the rabbit temporomandibular joint. J Oral Maxillofac Surg. 1992 ; 50: 843-849
101. Offenbacher S, Odle BM, Gray RC, Van Dyke TE. Crevicular fluid prostaglandin E levels as a measure of the periodontal disease status of adult and juvenile periodontitis patients. J Periodontal Res. 1984 ; 19: 1-13
102. Offenbacher S, Odle BM, Green MD, Mayambala CS, Smith MA, Fritz ME, et al. Inhibition of human periodontal prostaglandin E2 synthesis with selected agents. Agents Actions. 1990 ; 29: 232-238 (Pubitemid 20098450)
103. Offenbacher S, Heasman PA, Collins JG. Modulation of host PGE2 secretion as a determinant of periodontal disease expression. J Periodontol. 1993 ; 64 (5 Suppl). 432S - 444S
104. Offenbacher S, Barros SP, Beck JD. Rethinking periodontal inflammation. J Periodontol. 2008 ; 79 (8 Suppl). 1577S - 1584S
105. Paquette DW, Fiorellini JP, Martuscelli G, Oringer RJ, Howell TH, McCullough JR, et al. Enantiospecific inhibition of ligature-induced periodontitis in beagles with topical (S)-ketoprofen. J Clin Periodontol. 1997 ; 24: 521-528 (Pubitemid 127731566)
106. Pepelassi EM, Bissada NF, Greenwell H, Farah CF. Doxycycline-tricalcium phosphate composite graft facilitates osseous healing in advanced periodontal furcation defects. J Periodontol. 1991 ; 62: 106-115
107. Preshaw PM, Heasman PA. Prostaglandin E2 concentrations in gingival crevicular fluid: observations in untreated chronic periodontitis. J Clin Periodontol. 2002 ; 29: 15-20 (Pubitemid 41697729)
108. Quirynen M, De Soete M, Boschmans G, Pauwels M, Coucke W, Teughels W, et al. Benefit of "one-stage full-mouth disinfection" is explained by disinfection and root planing within 24 hours: a randomized controlled trial. J Clin Periodontol. 2006 ; 33: 639-647 (Pubitemid 44195416)
109. Raisz LG. Prostaglandins and bone: physiology and pathophysiology. Osteoarthritis Cartilage. 1999 ; 7: 419-421 (Pubitemid 29331567)
110. Reynolds MA, Prudencio A, Aichelmann-Reidy ME, Woodward K, Uhrich KE. Non-steroidal anti-inflammatory drug (NSAID)-derived poly(anhydride-esters) in bone and periodontal regeneration. Curr Drug Deliv. 2007 ; 4: 233-239 (Pubitemid 47025407)
111. Rosenberg A Pathologic basis of disease. Kumar V Abbas A Fausto N, ed. St. Louis: Saunders-Elsevier ; 2005: 1273-1324.
112. Ryan ME, Golub LM. Modulation of matrix metalloproteinase activities in periodontitis as a treatment strategy. Periodontol 2000. 2000 ; 24: 226-238
113. Sabanai K, Tsutsui M, Sakai A, Hirasawa H, Tanaka S, Nakamura E, et al. Genetic disruption of all NO synthase isoforms enhances BMD and bone turnover in mice in vivo: involvement of the renin-angiotensin system. J Bone Miner Res. 2008 ; 23: 633-643 (Pubitemid 351575017)
114. Salvi GE, Lang NP. The effects of non-steroidal anti-inflammatory drugs (selective and non-selective) on the treatment of periodontal diseases. Curr Pharm Des. 2005 ; 11: 1757-1769 (Pubitemid 40668134)
115. Sander L, Karring T. New attachment and bone formation in periodontal defects following treatment of submerged roots with guided tissue regeneration. J Clin Periodontol. 1995 ; 22: 295-299
116. Saura M, Tarin C, Zaragoza C. Recent insights into the implication of nitric oxide in osteoblast differentiation and proliferation during bone development. ScientificWorldJOURNAL. 2010 ; 10: 624-632
117. Sbordone L, Barone A, Di Genio M, Ramaglia L. Tetracycline fibres used to control bacterial infection during guided tissue regeneration (GTR). Minerva Stomatol. 2000 ; 49: 27-34
118. Schwartz AV. Diabetes mellitus: does it affect bone?. Calcif Tissue Int. 2003 ; 73: 515-519 (Pubitemid 37517795)
119. Serhan CN. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol. 2007 ; 25: 101-137 (Pubitemid 46697904)
120. Serhan CN. Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators. J Thromb Haemost. 2009 ; 7 (Suppl 1). 44-48
121. Simon AM, O'Connor JP. Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing. J Bone Joint Surg Am. 2007 ; 89: 500-511 (Pubitemid 46365350)
122. Smith MacDonald E, Nowzari H, Contreras A, Flynn J, Morrison J, Slots J. Clinical and microbiological evaluation of a bioabsorbable and a nonresorbable barrier membrane in the treatment of periodontal intraosseous lesions. J Periodontol. 1998 ; 69: 445-453 (Pubitemid 28259117)
123. Sorsa T, Tjäderhane L, Konttinen YT, Lauhio A, Salo T, Lee HM, et al. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med. 2006 ; 38: 306-321 (Pubitemid 44385100)
124. Spite M, Norling LV, Summers L, Yang R, Cooper D, Petasis NA, et al. Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature. 2009 ; 461: 1287-1291
125. Takagi M, Kasayama S, Yamamoto T, Motomura T, Hashimoto K, Yamamoto H, et al. Advanced glycation endproducts stimulate interleukin-6 production by human bone-derived cells. J Bone Miner Res. 1997 ; 12: 439-446 (Pubitemid 27120481)
126. Tornkvist H, Lindholm TS, Netz P, Stromberg L, Lindholm TC. Effect of ibuprofen and indomethacin on bone metabolism reflected in bone strength. Clin Orthop Relat Res. 1984 ; 187: 255-259 (Pubitemid 14063255)
127. Trombelli L, Schincaglia GP, Scapoli C, Calura G. Healing response of human buccal gingival recessions treated with expanded polytetrafluoroethylene membranes. A retrospective report. J Periodontol. 1995 ; 66: 14-22
128. van't Hof RJ, Ralston SH. Nitric oxide and bone. Immunology. 2001 ; 103: 255-261 (Pubitemid 32626174)
129. Vuolteenaho K, Moilanen T, Moilanen E. Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process. Basic Clin Pharmacol Toxicol. 2008 ; 102: 10-14 (Pubitemid 350294081)
130. Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol. 2007 ; 25: 821-852 (Pubitemid 46697925)
131. Weber HP, Fiorellini JP, Paquette DW, Howell TH, Williams RC. Inhibition of peri-implant bone loss with the nonsteroidal anti-inflammatory drug flurbiprofen in beagle dogs. A preliminary study. Clin Oral Implants Res. 1994 ; 5: 148-153
132. Williams RC, Jeffcoat MK, Kaplan ML, Goldhaber P, Johnson HG, Wechter WJ. Flurbiprofen: a potent inhibitor of alveolar bone resorption in beagles. Science. 1985 ; 227: 640-642 (Pubitemid 15157484)
133. Williams RC, Jeffcoat MK, Howell TH, Rolla A, Stubbs D, Teoh KW, et al. Altering the progression of human alveolar bone loss with the non-steroidal anti-inflammatory drug flurbiprofen. J Periodontol. 1989 ; 60: 485-490 (Pubitemid 19260094)
134. Wimalawansa SJ. Nitric oxide: novel therapy for osteoporosis. Expert Opin Pharmacother. 2008 ; 9: 3025-3044
135. Wimalawansa SJ. Nitric oxide and bone. Ann NY Acad Sci. 2010 ; 1192: 391-403
136. Wixted JJ, Fanning PJ, Gaur T, O'Connell SL, Silva J, Mason-Savas A, et al. Enhanced fracture repair by leukotriene antagonism is characterized by increased chondrocyte proliferation and early bone formation: a novel role of the cysteinyl LT-1 receptor. J Cell Physiol. 2009 ; 221: 31-39
137. Yang X, Ricciardi BF, Hernandez-Soria A, Shi Y, Pleshko Camacho N, Bostrom MP. Callus mineralization and maturation are delayed during fracture healing in interleukin-6 knockout mice. Bone. 2007 ; 41: 928-936 (Pubitemid 350116738)
138. Yoshinari N, Tohya T, Mori A, Koide M, Kawase H, Takada T, et al. Inflammatory cell population and bacterial contamination of membranes used for guided tissue regenerative procedures. J Periodontol. 1998 ; 69: 460-469 (Pubitemid 28259119)
139. Yoshinari N, Tohya T, Kawase H, Matsuoka M, Nakane M, Kawachi M, et al. Effect of repeated local minocycline administration on periodontal healing following guided tissue regeneration. J Periodontol. 2001 ; 72: 284-295 (Pubitemid 32524492)
140. Zaragoza C, Lopez-Rivera E, Garcia-Rama C, Saura M, Martinez-Ruiz A, Lizarbe TR, et al. Cbfa-1 mediates nitric oxide regulation of MMP-13 in osteoblasts. J Cell Sci. 2006 ; 119 (Pt 9). 1896-1902 (Pubitemid 43811014)
141. Zarkesh N, Nowzari H, Morrison JL, Slots J. Tetracycline-coated polytetrafluoroethylene barrier membranes in the treatment of intraosseous periodontal lesions. J Periodontol. 1999 ; 70: 1008-1016 (Pubitemid 29453276)
142. Zucchelli G, Sforza NM, Clauser C, Cesari C, De Sanctis M. Topical and systemic antimicrobial therapy in guided tissue regeneration. J Periodontol. 1999 ; 70: 239-247 (Pubitemid 29180791)